MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$5,618K
(-240.66%↓ Y/Y)
Net (loss) income
from continuing...
-$5,618K
(-242.59%↓ Y/Y)
ADHDPortfolio
$9,093K
EXXUAPortfolio
$2,397K
The Pediatric
Portfolio
$921K
(loss) income from
continuing operations...
-$5,608K
(-246.88%↓ Y/Y)
Income tax (expense)
benefit
$10K
(108.20%↑ Y/Y)
Other income, net
$149K
(313.89%↑ Y/Y)
Net revenue
$12,411K
(-32.74%↓ Y/Y)
(loss) income from
operations
-$4,064K
(-267.86%↓ Y/Y)
Derivative warrant
liabilities (loss) gain
-$1,257K
(-155.59%↓ Y/Y)
Interest expense
$436K
(-51.56%↓ Y/Y)
Gross profit
$7,599K
(-40.66%↓ Y/Y)
Cost of goods sold
$4,812K
(-14.77%↓ Y/Y)
Total operating
expenses
$11,663K
(12.31%↑ Y/Y)
Selling and marketing
$5,929K
(14.15%↑ Y/Y)
General and
administrative
$4,973K
(21.03%↑ Y/Y)
Amortization of intangible
assets
$761K
(-17.28%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)